Bosnia and Herzegovina vs Guatemala: Domestic private health expenditure (PVT-D) per capita in US$
Bosnia and Herzegovina
242.9
in 2023
Guatemala
239.98
in 2023
Bosnia and Herzegovina rank
73rd
Guatemala rank
74th
Domestic private health expenditure (PVT-D) per capita in US$ over time
- Bosnia and Herzegovina
- Guatemala
How they compare
Bosnia and Herzegovina currently reports 242.9 against 239.98 in Guatemala, a difference of 2.92.
The two have swapped places 3 times across 24 shared years of data; in 2000 it was Guatemala ahead.
Bosnia and Herzegovina ranks 73rd and Guatemala ranks 74th of 194 countries.
Across the 3 decades both report, Bosnia and Herzegovina averaged higher in 1 and Guatemala in 2.
Head to head by decade
| Decade | Bosnia and Herzegovina | Guatemala | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.93 | 84.25 | 16.68 | Bosnia and Herzegovina |
| 2010s | 138.82 | 139.73 | 0.9092 | Guatemala |
| 2020s | 210.38 | 222.53 | 12.15 | Guatemala |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher domestic private health expenditure (pvt-d) per capita in us$, Bosnia and Herzegovina or Guatemala?
- Bosnia and Herzegovina, at 242.9 against 239.98 in Guatemala as of 2023.
- What is the difference in domestic private health expenditure (pvt-d) per capita in us$ between Bosnia and Herzegovina and Guatemala?
- 2.92, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Guatemala?
- 24 years are reported by both, from 2000 to 2023.
- How do Bosnia and Herzegovina and Guatemala rank globally for domestic private health expenditure (pvt-d) per capita in us$?
- Bosnia and Herzegovina ranks 73rd and Guatemala ranks 74th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Domestic private health expenditure (PVT-D) per capita in US$. Statizoid refreshes it automatically from the source and publishes the full history for both places.